77 related articles for article (PubMed ID: 1544486)
1. The rate of catabolism of dATP to deoxyadenosine during the growth of different cell lines in vitro.
Marcussen M; Klenow H
FEBS Lett; 1992 Mar; 299(2):143-5. PubMed ID: 1544486
[TBL] [Abstract][Full Text] [Related]
2. Dynamics of the dATP pool in cultured mammalian cells.
Bianchi V; Pontis E; Reichard P
Exp Cell Res; 1992 Mar; 199(1):120-8. PubMed ID: 1735453
[TBL] [Abstract][Full Text] [Related]
3. Different relationships between cellular adenosine or 3'-deoxyadenosine phosphorylation and cellular adenine ribonucleotide catabolism may be obtained.
Overgaard-Hansen K; Klenow H
J Cell Physiol; 1993 Jan; 154(1):71-9. PubMed ID: 8419409
[TBL] [Abstract][Full Text] [Related]
4. Dipyridamole enhancement of toxicity to L1210 cells by deoxyadenosine and deoxycoformycin combinations in vitro.
Kang GJ; Kimball AP
Cancer Res; 1984 Feb; 44(2):461-6. PubMed ID: 6362851
[TBL] [Abstract][Full Text] [Related]
5. Biochemical basis for the enhanced toxicity of deoxyribonucleosides toward malignant human T cell lines.
Carson DA; Kaye J; Matsumoto S; Seegmiller JE; Thompson L
Proc Natl Acad Sci U S A; 1979 May; 76(5):2430-3. PubMed ID: 313056
[TBL] [Abstract][Full Text] [Related]
6. Characterization of adenosine deaminase (ADA)-negative B-lymphoblastoid cells cocultured with ADA-positive fibroblasts.
Fujita M; Ito K; Kawamoto H; Kashii S; Norioka M; Monden S; Okuma M
Eur J Haematol; 1993 Apr; 50(4):200-5. PubMed ID: 8500601
[TBL] [Abstract][Full Text] [Related]
7. Two novel dATP analogs for DNA photoaffinity labeling.
Zofall M; Bartholomew B
Nucleic Acids Res; 2000 Nov; 28(21):4382-90. PubMed ID: 11058139
[TBL] [Abstract][Full Text] [Related]
8. Resistance of an adenosine kinase-deficient human lymphoblastoid cell line to effects of deoxyadenosine on growth, S-adenosylhomocysteine hydrolase inactivation, and dATP accumulation.
Hershfield MS; Kredich NM
Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4292-6. PubMed ID: 6254019
[TBL] [Abstract][Full Text] [Related]
9. Ratio of 2'-deoxyadenosine-5'-triphosphate/thymidine-5'-triphosphate influences the commitment of human colon carcinoma cells to thymineless death.
Houghton JA; Tillman DM; Harwood FG
Clin Cancer Res; 1995 Jul; 1(7):723-30. PubMed ID: 9816038
[TBL] [Abstract][Full Text] [Related]
10. Enhanced cytotoxicity and inhibition of DNA damage repair in irradiated murine L5178Y lymphoblasts and human chronic lymphocytic leukemia cells treated with 2'-deoxycoformycin and deoxyadenosine in vitro.
Begleiter A; Pugh L; Israels LG; Johnston JB
Cancer Res; 1988 Jul; 48(14):3981-6. PubMed ID: 3260129
[TBL] [Abstract][Full Text] [Related]
11. Increased susceptibility of fibroblasts from horses with severe combined immunodeficiency to growth inhibition by 2'-deoxyadenosine.
Magnuson NS; Decker DM; Perryman LE
Clin Immunol Immunopathol; 1983 Dec; 29(3):391-402. PubMed ID: 6605826
[TBL] [Abstract][Full Text] [Related]
12. Cellular responses in mouse leukemia L1210 cells made resistant to deoxyadenosine.
Cory AH; Cory JG
Biochem Biophys Res Commun; 1998 Aug; 249(3):687-91. PubMed ID: 9731198
[TBL] [Abstract][Full Text] [Related]
13. Purinogenic immunodeficiency diseases: selective toxicity of deoxyribonucleosides for T cells.
Mitchell BS; Mejias E; Daddona PE; Kelley WN
Proc Natl Acad Sci U S A; 1978 Oct; 75(10):5011-4. PubMed ID: 311004
[TBL] [Abstract][Full Text] [Related]
14. Effects of mutational loss of adenosine kinase and deoxycytidine kinase on deoxyATP accumulation and deoxyadenosine toxicity in cultured CEM human T-lymphoblastoid cells.
Hershfield MS; Fetter JE; Small WC; Bagnara AS; Williams SR; Ullman B; Martin DW; Wasson DB; Carson DA
J Biol Chem; 1982 Jun; 257(11):6380-6. PubMed ID: 6281270
[No Abstract] [Full Text] [Related]
15. Overproduction of adenine deoxynucleosides and deoxynucletides in adenosine deaminase deficiency with severe combined immunodeficiency disease.
Donofrio J; Coleman MS; Hutton JJ; Daoud A; Lampkin B; Dyminski J
J Clin Invest; 1978 Oct; 62(4):884-7. PubMed ID: 308954
[TBL] [Abstract][Full Text] [Related]
16. B cells as well as T cells form deoxynucleotides from either deoxyadenosine or deoxyguanosine.
Goday A; Simmonds HA; Morris GS; Fairbanks LD
Clin Exp Immunol; 1984 Apr; 56(1):39-48. PubMed ID: 6424986
[TBL] [Abstract][Full Text] [Related]
17. Adenosine kinase inhibition promotes survival of fetal adenosine deaminase-deficient thymocytes by blocking dATP accumulation.
Van De Wiele CJ; Vaughn JG; Blackburn MR; Ledent CA; Jacobson M; Jiang H; Thompson LF
J Clin Invest; 2002 Aug; 110(3):395-402. PubMed ID: 12163459
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of deoxyadenosine-induced catabolism of adenine ribonucleotides in adenosine deaminase-inhibited human T lymphoblastoid cells.
Bagnara AS; Hershfield MS
Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2673-7. PubMed ID: 6283540
[TBL] [Abstract][Full Text] [Related]
19. S-adenosylhomocysteine hydrolase inactivation and purine toxicity in cultured human T- and B-lymphoblasts.
Young GJ; Hallam LJ; Jack I; Van Der Weyden MB
J Lab Clin Med; 1984 Jul; 104(1):86-95. PubMed ID: 6330251
[TBL] [Abstract][Full Text] [Related]
20. Formation and degradation of deoxyadenosine nucleotides in inherited adenosine deaminase deficiency.
Simmonds HA; Webster DR; Perrett D; Reiter S; Levinsky RJ
Biosci Rep; 1982 May; 2(5):303-14. PubMed ID: 6980023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
